Skip to main content
Caplight Logo









Monument Biosciences

Monument Biosciences

Private
Indianapolis, IndianaHealthcare & Life Scienceshttps://www.monument.bio/

Last Round

Seed

Jan 1, 2024

Total Funding Raised

$1.78M

Company Overview

Monument Biosciences is a biotechnology company developing translational biomarkers and disease-modifying drugs for Alzheimer's disease and related dementias.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share

AI Layer

Non-AI

Keywords

Alzheimer's disease drugneuroinflammationpreclinical biotechdrug discoverysmall moleculesgenetically validated targetsasset-centric biotechADRDINPP5D inhibitorPLCG2 activatorCNS drugsmicroglial functionneurodegenerative diseaseacademic spinoutpublic-private partnershipAlzheimer's Disease and Related Dementias

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Monument Biosciences Comparables

Compare Monument Biosciences with similar companies based on industry and business-model similarity.

Monument Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioClec
85%
MindImmune Therapeutics, Inc.
83%
AstronauTx
82%

Monument Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 1, 2024

Monument Biosciences Investors

Notable investors and investment history

Monument Biosciences investors
InvestorRounds
Dolby Family VenturesSeed
Elevate VenturesSeed
IU VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 19, 2024

    Grew 33% QoQ from 9 to 12 employees.

  • Jan 1, 2024

    $1.78M round led by IU Ventures, Dolby Family Ventures, and Elevate Ventures.

Monument Biosciences Filings

Explore SEC and related filing metadata, where available.

Monument Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Monument Biosciences's valuation, stock price, and market status.

Is Monument Biosciences a public or private company?

Monument Biosciences is a private company.

What is the current stock price of Monument Biosciences?

Monument Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is Monument Biosciences worth (valuation)?

Valuation information for Monument Biosciences is not publicly available.

Can I buy Monument Biosciences stock?

Monument Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Monument Biosciences's last funding round?

Monument Biosciences's most recent funding round was Seed on January 1, 2024.

Who are the main investors in Monument Biosciences?

Key investors in Monument Biosciences include Dolby Family Ventures, Elevate Ventures, IU Ventures.

Will Monument Biosciences IPO soon?

No public IPO plans have been announced for Monument Biosciences.

How can I track Monument Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Monument Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIndianapolis, Indiana
Employee Range11
Year Founded2022
Last FundingJan 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?